AIDX 20/20 Biolabs, Inc.
Company Analysis
Latest News
AIDX Outlines M&A Strategy and Path to Medicare Reimbursement for OneTest
In a new investor presentation, 20/20 Biolabs (AIDX) detailed its corporate strategy, which includes a new "bolt-on" acquisition plan and its pathway to...
🟢 AIDX makes sharp 15.3% jump
AIDX is trading at $0.63, up 15.3% versus the comparison close of $0.55 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 AIDX Rises 5.2% on Technical Bounce, Amidst Investor Webinar
AIDX is trading 5.2% up at $0.58 in a technical bounce following yesterday's sharp 7.9% decline. The company is hosting a monthly investor webinar today, which...
🔴 AIDX makes sharp 10.7% drop
AIDX is trading at $0.53, down 10.7% versus the comparison close of $0.60 during regular trading. This is a price-movement alert; no separate company-specific...
20/20 Biolabs, Inc. Q1 2026 Earnings Preview: What Analysts Expect on June 30, 2026
20/20 Biolabs, Inc. is expected to report Q1 2026 revenue of $1.85 million and a net loss of $0.03 per share, while the stock’s current price of $1.12 sits...
🟢 AIDX is trading 5% up today in a modest rebound following recent volatility
AIDX is trading approximately 5% higher at $0.59 as the stock attempts a modest rebound following yesterday’s sharp drop and recent volatility. • No fresh...
🔴 AIDX makes sharp 12.6% drop
AIDX is trading at $0.55, down 12.6% versus the comparison close of $0.63 during regular trading. This is a price-movement alert; no separate company-specific...
🔴 AIDX is trading 6.1% down today amid dilution fears and extreme volatility
AIDX is trading 6.1% down today at $0.59 amid continued dilution worries and extreme volatility following its massive year-to-date collapse. • The stock has...
🔴 AIDX is trading 5.3% down today amid dilution concerns and extreme volatility
AIDX is trading 5.3% down at $0.60 amid ongoing dilution concerns and extreme volatility in the absence of fresh company-specific news. • The stock has...
🔴 20/20 Biolabs, Inc. is trading 5.3% down today on profit-taking after recent rally
20/20 Biolabs, Inc. is trading 5.3% down at $0.62 today as the stock experiences normal post-rally volatility and profit-taking following significant recent...
🔴 20/20 Biolabs, Inc. is trading 6.8% down today as post-rally pullback continues
20/20 Biolabs, Inc. is trading at $0.60 (-6.79%) in pre-market as the stock continues a pullback following its recent sharp rally and subsequent volatility. •...
🔴 20/20 Biolabs, Inc. is trading 5.4% down today in a post-rally pullback
20/20 Biolabs, Inc. is trading at $0.61, down 5.4% in after-hours activity, as the stock undergoes a modest pullback following a significant regular-session...
🟢 20/20 Biolabs, Inc. makes sharp 11.3% jump
AIDX is trading at $0.64, up 11.3% versus the comparison close of $0.57 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 20/20 Biolabs, Inc. is trading 8% up today as it rebounds from a recent selloff
20/20 Biolabs, Inc. is trading at $0.62 (+7.98%), extending a rebound from its prior close of $0.57 despite a lack of fresh company-specific news or...
🔴 20/20 Biolabs, Inc. is trading 5.5% down today, extending steep losses from the previous session
20/20 Biolabs, Inc. is trading 5.5% down at $0.56, extending steep recent losses after a nearly 38% drop on June 15, 2026. • The stock continues to drift...